An American bank disclosed that 22,000 customers were affected by a cyberattack exploiting a zero-day vulnerability in a third-party file-transfer tool, compromising their accounts.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
